---
title: 'Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3
  expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors
  combined with chemotherapy'
date: '2024-10-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39423775/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241019190408&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Our results suggest that ICI+chemo and DLL3-targeting agents
  are worth further exploration in EGFR+ NSCLC undergoing ...'
disable_comments: true
---
CONCLUSIONS: Our results suggest that ICI+chemo and DLL3-targeting agents are worth further exploration in EGFR+ NSCLC undergoing ...